Global Pharmaceutical Excipients Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012-2016 and Forecast 2017-2023

November 2017 | 209 pages | ID: G41A0519D61EN
Precision Business Insights (PBI)

Abstracts

Pharmaceutical excipients are combined with active pharmaceutical ingredients to produce the final dosage form of the drugs. The excipients provide bulkiness to formulation, facilitates absorption of the drug, provides stability and prevent from the drugs from denaturation. Pharmaceutical excipients are cost effective, stable, feasible for handling, and inert in the nature. The major advantages of using excipients are improving property of wetting, increase bulkiness of drug, provides stability, and improves the organoleptic properties of the drug. Excipients are used in a different medicinal products like capsules, tablets, oral liquids, inhalers, implants and injections among others.

Global pharmaceutical excipients market is driven by increase in demand for oral drugs. Factors such as patient compliance and ease in consumption forcing drug manufactures in developing a sustained release dosage formulations which contributes to the extension of shelf life of the oral drugs that adds to the high revenue anticipation of pharmaceutical excipients. However, lack of standard quality policies and regulations for excipients and safety evaluation is expected to hamper the growth of the market over the forecast period.

The Pharmaceutical Excipient Market has been segmented by product, function, end-user, and geography.

On the basis of product, pharmaceutical excipient market is segmented as:

• Inorganic Chemicals
• Calcium Phosphates
• Calcium Carbonate
• Calcium Sulphate
• Halides
• Metallic Oxides
• Organic Chemicals
• Carbohydrates
• Sugar
• Starch
• Cellulose
• Petrochemicals
• Glycols (alcohol)
• Povidones polymers
• Mineral Hydrocarbons
• Oleochemicals
• Gelatin (Proteins)

On the basis of function, pharmaceutical excipient market is segmented as:

• Fillers and diluents
• Coatings
• Binders
• Disintegrants
• Flavouring agents
• Colorants
• Others

On the basis of dosage form, pharmaceutical excipient market is segmented as:

• Tablets
• Capsules
• Liquids
• Injections
• Others

On the basis of the end-user, pharmaceutical excipient market is segmented as:

• Biotech Companies
• Pharmaceutical companies
• Research institutes
• Others

Global pharmaceutical excipient market is driven by growing demand for oral pharmaceuticals (solid) and development of novel therapeutics because of increase in pharmaceutical industries. The combination of nanotechnology and drug formulations in excipients led the development of nano-derived liposomes, vaccines, and nano coated tablets. The global pharmaceutical excipient market is expected to grow at a significant CAGR over the forecast period owing to increase in utilization of parenteral products, rise in the global burden of chronic & lifestyle diseases and increasing investments by the pharmaceutical industry on the development of biologics. Good manufacturing and distribution practices for for uniform excipients, spanning regions by international regulatory authorities is set to define the market landscape of the excipient industry over the forecast period. Business expansions, new product launches, mergers & acquisitions and collaborations with educational universities are the key strategies adopted by most companies in the global pharmaceutical excipients market.

The global market of pharmaceutical excipients is segmented into 5 key regions, North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa.. North America followed Europe dominates in terms of the size of the excipients market globally. Emerging market like Asia-Pacific is expected to show lucrative growth opportunity owing to the availability of lower labour cost, skilled work force in and low cost of raw materials. Countries such as Brazil, India, and China are expected to be the major contributors to the growth of pharmaceutical excipients market owing to rising percapita income and most of the companies present in developed regions willing to establish manufacturing facilities in developing regions due to their low cost of manufacturing and processing.

Some of the players operating in global pharmaceutical excipients market are Ashland Inc.(U.S.), AkzoNobel (Netherlands), The DOW Chemical Company (U.S.), Archer Daniels Midland Company(U.S.), Associated British Foods PLC (UK), Colorcon, Inc.(U.S.), BASF SE(Germany), Evonik Industries AG (Germany), Innophos Holdings Inc. (U.S.), J.M. Huber Corporation (U.S.), FMC Corporation (U.S.), Roquette Group (Nord-Pas de Calais), Croda International PLC (UK),Merck KGaA (U.S.) and Lubrizol Corporation (U.S.) to name a few.

In June 2017, Ashland Inc. got US patent for purekote 23589 (dispersion) and purekote 21412a (cross linking agent) coating system

In April 2017, Lubrizol Corporation's Skin Essentials division launched new acrylate-based polymeric emulsifier Pemulen EZ-4U

In July 2016, The Lubrizol Corporation acquired Diamond Dispersions Ltd to expand its product portfolio that enable digital painting

REPORT OUTLINE:

• The report provides granular level information about the market size, regional market share and forecast from 2017-2023
• The report covers in-detail insights about the competitor’s overview, key findings and their key strategies
• The report outlines drivers, restraints, challenges, and trends that are currently faced by the industry
• The report tracks recent innovations, key developments and startup’s details that are working in the industry
• The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario

Contents

1. EXECUTIVE SUMMARY

2. GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET INTRODUCTION

2.1. Global Pharmaceutical Excipients Market – Taxonomy
2.2. Global Pharmaceutical Excipients Market – Definitions
  2.2.1. Function
  2.2.2. Product Type

3. GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET DYNAMICS

3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Pharmaceutical Excipients Market Dynamics – Factors Impact Analysis

4. GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 – 2023

4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Oppurtunity Analysis

5. GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTION, 2012 - 2016 AND FORECAST, 2017 - 2023

5.1. Fillers and Diluents
  5.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  5.1.3. Market Opportunity Analysis
5.2. Coatings
  5.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  5.2.3. Market Opportunity Analysis
5.3. Binders
  5.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  5.3.3. Market Opportunity Analysis
5.4. Disintegrants
  5.4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  5.4.3. Market Opportunity Analysis
5.5. Flavouring Agents
  5.5.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  5.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  5.5.3. Market Opportunity Analysis
5.6. Colorants
  5.6.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  5.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  5.6.3. Market Opportunity Analysis
5.7. Others
  5.7.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  5.7.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  5.7.3. Market Opportunity Analysis

6. GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET FORECAST, BY PRODUCT TYPE, 2012 - 2016 AND FORECAST, 2017 - 2023

6.1. Inorganic Chemicals
  6.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  6.1.3. Market Opportunity Analysis
6.2. Organic Chemicals
  6.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  6.2.3. Market Opportunity Analysis
6.3. Petrochemicals
  6.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  6.3.3. Market Opportunity Analysis

7. GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET FORECAST, BY DOSAGE FORM, 2012 - 2016 AND FORECAST, 2017 - 2023

7.1. Tablets
  7.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  7.1.3. Market Opportunity Analysis
7.2. Capsules
  7.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  7.2.3. Market Opportunity Analysis
7.3. Liquids
  7.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  7.3.3. Market Opportunity Analysis
7.4. Injections
  7.4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  7.4.3. Market Opportunity Analysis
7.5. Others
  7.5.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  7.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  7.5.3. Market Opportunity Analysis

8. GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET FORECAST, BY END USER, 2012 - 2016 AND FORECAST, 2017 - 2023

8.1. Biotech Companies
  8.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  8.1.3. Market Opportunity Analysis
8.2. Pharmaceutical Companies
  8.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  8.2.3. Market Opportunity Analysis
8.3. Research Institutes
  8.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  8.3.3. Market Opportunity Analysis
8.4. Others
  8.4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  8.4.3. Market Opportunity Analysis

9. GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET FORECAST, BY REGION, 2012 - 2016 AND FORECAST, 2017 - 2023

9.1. North America
  9.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  9.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  9.1.3. Market Opportunity Analysis
9.2. Europe
  9.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  9.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  9.2.3. Market Opportunity Analysis
9.3. Asia-Pacific
  9.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  9.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  9.3.3. Market Opportunity Analysis
9.4. Latin America
  9.4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  9.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  9.4.3. Market Opportunity Analysis
9.5. Middle East and Africa
  9.5.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  9.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  9.5.3. Market Opportunity Analysis
9.6. Global Pharmaceutical Excipients Market- Opportunity Analysis Index - By Function, By Product Type, By Dosage Form, By End User, and Region, 2017 – 2023

10. NORTH AMERICA PHARMACEUTICAL EXCIPIENTS MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023

  10.1.1. Function Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
    10.1.1.1. Fillers and Diluents
    10.1.1.2. Coatings
    10.1.1.3. Binders
    10.1.1.4. Disintegrants
    10.1.1.5. Flavouring Agents
    10.1.1.6. Colorants
    10.1.1.7. Others
  10.1.2. Product Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    10.1.2.1. Inorganic Chemicals
      10.1.2.1.1. Calcium Phosphates
      10.1.2.1.2. Calcium Carbonate
      10.1.2.1.3. Calcium Sulphate
      10.1.2.1.4. Halides
      10.1.2.1.5. Metallic Oxides
    10.1.2.2. Organic Chemicals
      10.1.2.2.1. Carbohydrates
      10.1.2.2.2. Sugar
      10.1.2.2.3. Starch
      10.1.2.2.4. Cellulose
    10.1.2.3. Petrochemicals
      10.1.2.3.1. Glycols (alcohol)
      10.1.2.3.2. Povidones polymers
      10.1.2.3.3. Mineral Hydrocarbons
      10.1.2.3.4. Oleochemicals
      10.1.2.3.5. Gelatin (Proteins)
  10.1.3. Dosage Form Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    10.1.3.1. Tablets
    10.1.3.2. Capsules
    10.1.3.3. Liquids
    10.1.3.4. Injections
    10.1.3.5. Others
  10.1.4. End User Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    10.1.4.1. Biotech Companies
    10.1.4.2. Pharmaceutical Companies
    10.1.4.3. Research Institutes
    10.1.4.4. Others
  10.1.5. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
    10.1.5.1. U.S.
    10.1.5.2. Canada
  10.1.6. North America Infectious Disease Diagnostics Market- Opportunity Analysis Index - By Function, By Product Type, By Dosage Form, By End User, and Country, 2017 – 2023
  10.1.7. North America Pharmaceutical Excipients Market Dynamics – Trends

11. EUROPE PHARMACEUTICAL EXCIPIENTS MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023

  11.1.1. Function Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
    11.1.1.1. Fillers and Diluents
    11.1.1.2. Coatings
    11.1.1.3. Binders
    11.1.1.4. Disintegrants
    11.1.1.5. Flavouring Agents
    11.1.1.6. Colorants
    11.1.1.7. Others
  11.1.2. Product Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    11.1.2.1. Inorganic Chemicals
      11.1.2.1.1. Calcium Phosphates
      11.1.2.1.2. Calcium Carbonate
      11.1.2.1.3. Calcium Sulphate
      11.1.2.1.4. Halides
      11.1.2.1.5. Metallic Oxides
    11.1.2.2. Organic Chemicals
      11.1.2.2.1. Carbohydrates
      11.1.2.2.2. Sugar
      11.1.2.2.3. Starch
      11.1.2.2.4. Cellulose
    11.1.2.3. Petrochemicals
      11.1.2.3.1. Glycols (alcohol)
      11.1.2.3.2. Povidones polymers
      11.1.2.3.3. Mineral Hydrocarbons
      11.1.2.3.4. Oleochemicals
      11.1.2.3.5. Gelatin (Proteins)
  11.1.3. Dosage Form Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    11.1.3.1. Tablets
    11.1.3.2. Capsules
    11.1.3.3. Liquids
    11.1.3.4. Injections
    11.1.3.5. Others
  11.1.4. End User Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    11.1.4.1. Biotech Companies
    11.1.4.2. Pharmaceutical Companies
    11.1.4.3. Research Institutes
    11.1.4.4. Others
  11.1.5. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    11.1.5.1. Germany
    11.1.5.2. UK
    11.1.5.3. France
    11.1.5.4. Spain
    11.1.5.5. Italy
    11.1.5.6. Russia
    11.1.5.7. Poland
    11.1.5.8. Rest of Europe
  11.1.6. Europe Infectious Disease Diagnostics Market- Opportunity Analysis Index - By Function, By Product Type, By Dosage Form, By End User, and Country, 2017 – 2023
  11.1.7. Europe Pharmaceutical Excipients Market Dynamics – Trends

12. ASIA-PACIFIC PHARMACEUTICAL EXCIPIENTS MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023

  12.1.1. Function Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
    12.1.1.1. Fillers and Diluents
    12.1.1.2. Coatings
    12.1.1.3. Binders
    12.1.1.4. Disintegrants
    12.1.1.5. Flavouring Agents
    12.1.1.6. Colorants
    12.1.1.7. Others
  12.1.2. Product Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    12.1.2.1. Inorganic Chemicals
      12.1.2.1.1. Calcium Phosphates
      12.1.2.1.2. Calcium Carbonate
      12.1.2.1.3. Calcium Sulphate
      12.1.2.1.4. Halides
      12.1.2.1.5. Metallic Oxides
    12.1.2.2. Organic Chemicals
      12.1.2.2.1. Carbohydrates
      12.1.2.2.2. Sugar
      12.1.2.2.3. Starch
      12.1.2.2.4. Cellulose
    12.1.2.3. Petrochemicals
      12.1.2.3.1. Glycols (alcohol)
      12.1.2.3.2. Povidones polymers
      12.1.2.3.3. Mineral Hydrocarbons
      12.1.2.3.4. Oleochemicals
      12.1.2.3.5. Gelatin (Proteins)
  12.1.3. Dosage Form Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    12.1.3.1. Tablets
    12.1.3.2. Capsules
    12.1.3.3. Liquids
    12.1.3.4. Injections
    12.1.3.5. Others
  12.1.4. End User Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    12.1.4.1. Biotech Companies
    12.1.4.2. Pharmaceutical Companies
    12.1.4.3. Research Institutes
    12.1.4.4. Others
  12.1.5. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn),
Y-o-Y Growth (%), and Market Share (%)
    12.1.5.1. Japan
    12.1.5.2. China
    12.1.5.3. India
    12.1.5.4. ASEAN
    12.1.5.5. Australia & New Zealand
    12.1.5.6. Rest of Asia-Pacific
  12.1.6. Asia-Pacific Infectious Disease Diagnostics Market- Opportunity Analysis Index - By Function, By Product Type, By Dosage Form, By End User, and Country, 2017 – 2023
  12.1.7. Asia-Pacific Pharmaceutical Excipients Market Dynamics – Trends

13. LATIN AMERICA PHARMACEUTICAL EXCIPIENTS MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023

  13.1.1. Function Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
    13.1.1.1. Fillers and Diluents
    13.1.1.2. Coatings
    13.1.1.3. Binders
    13.1.1.4. Disintegrants
    13.1.1.5. Flavouring Agents
    13.1.1.6. Colorants
    13.1.1.7. Others
  13.1.2. Product Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    13.1.2.1. Inorganic Chemicals
      13.1.2.1.1. Calcium Phosphates
      13.1.2.1.2. Calcium Carbonate
      13.1.2.1.3. Calcium Sulphate
      13.1.2.1.4. Halides
      13.1.2.1.5. Metallic Oxides
    13.1.2.2. Organic Chemicals
      13.1.2.2.1. Carbohydrates
      13.1.2.2.2. Sugar
      13.1.2.2.3. Starch
      13.1.2.2.4. Cellulose
    13.1.2.3. Petrochemicals
      13.1.2.3.1. Glycols (alcohol)
      13.1.2.3.2. Povidones polymers
      13.1.2.3.3. Mineral Hydrocarbons
      13.1.2.3.4. Oleochemicals
      13.1.2.3.5. Gelatin (Proteins)
  13.1.3. Dosage Form Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    13.1.3.1. Tablets
    13.1.3.2. Capsules
    13.1.3.3. Liquids
    13.1.3.4. Injections
    13.1.3.5. Others
  13.1.4. End User Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    13.1.4.1. Biotech Companies
    13.1.4.2. Pharmaceutical Companies
    13.1.4.3. Research Institutes
    13.1.4.4. Others
  13.1.5. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    13.1.5.1. Brazil
    13.1.5.2. Mexico
    13.1.5.3. Argentina
    13.1.5.4. Venezuela
    13.1.5.5. Rest of Latin America
  13.1.6. Latin America Infectious Disease Diagnostics Market- Opportunity Analysis Index - By Function, By Product Type, By Dosage Form, By End User, and Country, 2017 – 2023
  13.1.7. Latin America Pharmaceutical Excipients Market Dynamics – Trends

14. MIDDLE EAST & AFRICA PHARMACEUTICAL EXCIPIENTS MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023

  14.1.1. Function Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
    14.1.1.1. Fillers and Diluents
    14.1.1.2. Coatings
    14.1.1.3. Binders
    14.1.1.4. Disintegrants
    14.1.1.5. Flavouring Agents
    14.1.1.6. Colorants
    14.1.1.7. Others
  14.1.2. Product Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    14.1.2.1. Inorganic Chemicals
      14.1.2.1.1. Calcium Phosphates
      14.1.2.1.2. Calcium Carbonate
      14.1.2.1.3. Calcium Sulphate
      14.1.2.1.4. Halides
      14.1.2.1.5. Metallic Oxides
    14.1.2.2. Organic Chemicals
      14.1.2.2.1. Carbohydrates
      14.1.2.2.2. Sugar
      14.1.2.2.3. Starch
      14.1.2.2.4. Cellulose
    14.1.2.3. Petrochemicals
      14.1.2.3.1. Glycols (alcohol)
      14.1.2.3.2. Povidones polymers
      14.1.2.3.3. Mineral Hydrocarbons
      14.1.2.3.4. Oleochemicals
      14.1.2.3.5. Gelatin (Proteins)
  14.1.3. Dosage Form Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    14.1.3.1. Tablets
    14.1.3.2. Capsules
    14.1.3.3. Liquids
    14.1.3.4. Injections
    14.1.3.5. Others
  14.1.4. End User Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    14.1.4.1. Biotech Companies
    14.1.4.2. Pharmaceutical Companies
    14.1.4.3. Research Institutes
    14.1.4.4. Others
  14.1.5. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
    14.1.5.1. Gulf Cooperation Council (GCC) Countries
    14.1.5.2. Israel
    14.1.5.3. South Africa
    14.1.5.4. Rest of MEA
  14.1.6. MEA Infectious Disease Diagnostics Market- Opportunity Analysis Index - By Function, By Product Type, By Dosage Form, By End User, and Country, 2017 – 2023
  14.1.7. MEA Pharmaceutical Excipients Market Dynamics – Trends

15. COMPETITION LANDSCAPE

15.1. Strategic Dashboard of Top Market Players
15.2. Company Profiles (Introduction, Financial Analysis, Drug & Service Offerings, Key Developments, Strategies, and SWOT Analysis)
  15.2.1. Ashland Inc.(U.S.)
  15.2.2. AkzoNobel (Netherlands)
  15.2.3. The DOW Chemical Company (U.S.)
  15.2.4. Archer Daniels Midland Company(U.S.)
  15.2.5. Associated British Foods PLC (UK)
  15.2.6. Colorcon, Inc.(U.S.)
  15.2.7. BASF SE(Germany)
  15.2.8. Evonik Industries AG (Germany)
  15.2.9. Innophos Holdings Inc. (U.S.)
  15.2.10. J.M. Huber Corporation (U.S.)
  15.2.11. FMC Corporation (U.S.)
  15.2.12. Roquette Group (Nord-Pas de Calais)
  15.2.13. Croda International PLC (UK)
  15.2.14. Merck KGaA (U.S.)
  15.2.15. Lubrizol Corporation (U.S.)

16. RESEARCH METHODOLOGY

17. KEY ASSUMPTIONS AND ACRONYMS